May 25, 2026
SOHO Insider Hem/Onc Library Multiple Myeloma

Multiple Myeloma News

SOHO 2026 Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma T-Cell Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms Society Updates

Registration now open for SOHO 2026, receive early bird rates until June 10

Jeffrey Matous
Community Oncology News Community Oncology Cellular Therapy Multiple Myeloma Video Interviews

Dr. Jeffrey Matous on managing access to novel agents in the community setting

blood smear
Leukemia Chronic Lymphocytic Leukemia Multiple Myeloma

Researchers find concomitant MM and CLL are clonally unrelated

New community oncology sessions
Community Oncology News Leukemia Acute Lymphoblastic Leukemia Lymphoma Aggressive B-Cell Lymphomas Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News

Drs. Krish Patel and Gwen Nichols join SOHO Insider community oncology series

SOHO UK Leukemia Acute Lymphoblastic Leukemia Multiple Myeloma Myelodysplastic Syndromes News Video Interviews

Dr. Jessica Manson discusses multidisciplinary HLH management at SOHO UK

Cellular Therapy Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Multiple Myeloma Myelodysplastic Syndromes News

Why clinicians should lead hospitals, according to Prof. Amanda Goodall

FDA stamp on white paper
Cellular Therapy Multiple Myeloma News

FDA accepts NDA for iberdomide in relapsed/refractory myeloma

FDA laptop
Multiple Myeloma News

FDA approves teclistamab combo in relapsed myeloma

Multiple Myeloma

Clinical trial criteria exclude over 40% of real-world patients with AL amyloidosis

FDA editorial
Multiple Myeloma News

FDA issues draft guidance on MRD, CR endpoints in MM clinical trials